\-\ Texto\\:\\ \ \(0\)\
\-\ skin\\ dimple\\ in\\ midline\\ just\\ above\\ buttocks\\.\ \(0\)\
\-\ no\\ hairy\\ patch\\ or\\ csf\\ leak\ \(0\)\
\-\ unknown\ \(157\)\
\-\ \\â\\€\\¢\\ tethered\\ spinal\\ cord\ \(0\)\
\-\ \\â\\€\\¢\\ conus\\ noted\\ to\\ be\\ at\\ the\\ lower\\ l3\\ level\ \(0\)\
\-\ \\â\\€\\¢\\ dermal\\ sinus\\ tract\\ present\\ in\\ midline\\ at\\ l4\\ level\\ and\\ extending\\ inferiorly\\ to\\ enter\\ spinal\\ canal\\ at\\ s1\\/\\ s2\\ level\ \(0\)\
\-\ \\â\\€\\¢\\ occult\\ dysraphism\\ with\\ failure\\ of\\ closure\\ of\\ l5\\ posterior\\ elements\ \(0\)\
\-\ tethered\\ cord\\ due\\ to\\ dorsal\\ dermal\\ sinus\ \(0\)\
\-\ \\â\\€\\¢\\ lipoma\ \(1\)\
\-\ \\â\\€\\¢\\ myelomeningocele\ \(0\)\
\-\ \\â\\€\\¢\\ dermal\\ sinus\ \(0\)\
\-\ \\â\\€\\¢\\ diastametamyelia\ \(0\)\
\-\ 4\\ month\\ old\\ baby\\ boy\\ with\\ a\\ history\\ of\\ birth\\ asphyxia\\.\ \(1\)\
\-\ a\\ dimple\\ was\\ noted\\ in\\ midline\\ lower\\ back\\ just\\ above\\ buttocks\\.\ \(0\)\
\-\ dorsal\\ dermal\\ sinuses\\ result\\ from\\ a\\ focal\\ area\\ of\\ nondysjunction\\ of\\ the\\ neural\\ and\\ cutaneous\\ ectoderm\\ during\\ the\\ formation\\ of\\ the\\ neural\\ tube\\ \\(neurualtion\\)\\.\\ this\\ results\\ in\\ a\\ thin\\ epithelial\\ lined\\ channel\\ that\\ extends\\ inward\\ from\\ the\\ skin\\ surface\\ for\\ varying\\ distances\\.\\ penetration\\ into\\ the\\ the\\ spinal\\ canal\\ occurs\\ in\\ up\\ to\\ 70\\%\\ of\\ cases\\.\ \(0\)\
\-\ dermal\\ sinuses\\ are\\ typically\\ midline\\,\\ but\\ may\\ be\\ paramedian\\.\\ \\ a\\ skin\\ dimple\\ is\\ present\\,\\ and\\ any\\ dimple\\ above\\ the\\ gluteal\\ fold\\ must\\ be\\ presumed\\ to\\ extend\\ into\\ the\\ spinal\\ canal\\ until\\ proven\\ otherwise\\.\\ the\\ dimple\\ is\\ requently\\ associated\\ with\\ a\\ hairy\\ or\\ hyperpigemented\\ patch\\,\\ or\\ capillary\\ angioma\\.\ \(0\)\
\-\ patients\\ may\\ become\\ symptomatic\\ due\\ to\\ \\ infection\\ or\\ by\\ compression\\ of\\ neural\\ structures\\ by\\ an\\ associated\\ dermoid\\ or\\ epidermoid\\.\\ \\ \\ \\ a\\ chemical\\ meningitis\\ may\\ result\\ from\\ rupture\\ of\\ the\\ dermoid\\ or\\ epidermoid\\.\ \(0\)\
\-\ t1\\ and\\ t2\\-weighted\\ sequences\\ may\\ demonstrate\\ the\\ sinus\\ tract\\ coursing\\ obliquely\\ through\\ the\\ subcutaneous\\ tissues\\.\\ if\\ the\\ tract\\ extends\\ intrathecally\\ it\\ may\\ be\\ difficult\\ to\\ visualize\\ on\\ mri\\.\\ ct\\ myelography\\ may\\ help\\ demonstrate\\ the\\ intrathecal\\ component\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ dimple\\:\\ 0\\.10889493147221187\ \(0\)\
\-\ dermal\\:\\ 0\\.09972954652627494\ \(0\)\
\-\ hairy\\:\\ 0\\.05660189019795507\ \(0\)\
\-\ midline\\:\\ 0\\.04607846811621632\ \(0\)\
\-\ neural\\:\\ 0\\.045228732274226746\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.04367984255319548\ \(0\)\
\-\ sinus\\:\\ 0\\.043556222573413766\ \(0\)\
\-\ spinal\\:\\ 0\\.042644964604593535\ \(0\)\
\-\ patch\\:\\ 0\\.040913445608362776\ \(0\)\
\-\ buttocks\\:\\ 0\\.04055600104817078\ \(0\)\
\-\ tethered\\:\\ 0\\.03989181861050998\ \(0\)\
\-\ tract\\:\\ 0\\.0395653014206348\ \(0\)\
\-\ may\\:\\ 0\\.0391845652034451\ \(0\)\
\-\ canal\\:\\ 0\\.035487631617012676\ \(0\)\
\-\ skin\\:\\ 0\\.0343079679641705\ \(0\)\
\-\ above\\:\\ 0\\.03273803473826986\ \(0\)\
\-\ s1\\/\\:\\ 0\\.03071609206956968\ \(0\)\
\-\ diastametamyelia\\:\\ 0\\.03071609206956968\ \(0\)\
\-\ nondysjunction\\:\\ 0\\.03071609206956968\ \(0\)\
\-\ neurualtion\\:\\ 0\\.03071609206956968\ \(0\)\
\-\ requently\\:\\ 0\\.03071609206956968\ \(0\)\
\-\ hyperpigemented\\:\\ 0\\.03071609206956968\ \(0\)\
\-\ sinuses\\:\\ 0\\.03063886979909338\ \(0\)\
\-\ dorsal\\:\\ 0\\.030310873207748532\ \(0\)\
\-\ epidermoid\\:\\ 0\\.028366455021625422\ \(0\)\
\-\ asphyxia\\:\\ 0\\.028300945098977535\ \(0\)\
\-\ dermoid\\:\\ 0\\.027146602774483438\ \(0\)\
\-\ intrathecally\\:\\ 0\\.02688817468745083\ \(0\)\
\-\ myelography\\:\\ 0\\.02588579812838539\ \(0\)\
\-\ extends\\:\\ 0\\.025808575857909095\ \(0\)\
\-\ level\\:\\ 0\\.025744484609549815\ \(0\)\
\-\ inward\\:\\ 0\\.02510829446526968\ \(0\)\
\-\ distances\\:\\ 0\\.02510829446526968\ \(0\)\
\-\ just\\:\\ 0\\.024867556458578483\ \(0\)\
\-\ ectoderm\\:\\ 0\\.024473027716858685\ \(0\)\
\-\ dysraphism\\:\\ 0\\.02306025730533198\ \(0\)\
\-\ result\\:\\ 0\\.02284448889859207\ \(0\)\
\-\ paramedian\\:\\ 0\\.022693147494677535\ \(0\)\
\-\ gluteal\\:\\ 0\\.022693147494677535\ \(0\)\
\-\ intrathecal\\:\\ 0\\.022693147494677535\ \(0\)\
\-\ cord\\:\\ 0\\.022628389687842518\ \(0\)\
\-\ myelomeningocele\\:\\ 0\\.022057880746266544\ \(0\)\
\-\ obliquely\\:\\ 0\\.022057880746266544\ \(0\)\
\-\ lined\\:\\ 0\\.02128037708315083\ \(0\)\
\-\ or\\:\\ 0\\.020937757818056606\ \(0\)\
\-\ enter\\:\\ 0\\.020844268571115966\ \(0\)\
\-\ coursing\\:\\ 0\\.020456722804181388\ \(0\)\
\-\ fold\\:\\ 0\\.01979102511511271\ \(0\)\
\-\ channel\\:\\ 0\\.0196427337756744\ \(0\)\
\-\ penetration\\:\\ 0\\.0196427337756744\ \(0\)\
\-\ visualize\\:\\ 0\\.018533138893728283\ \(0\)\
\-\ be\\:\\ 0\\.018365947363678456\ \(0\)\
\-\ chemical\\:\\ 0\\.018328119729885312\ \(0\)\
\-\ epithelial\\:\\ 0\\.018134496555129873\ \(0\)\
\-\ conus\\:\\ 0\\.017951068912323526\ \(0\)\
\-\ occult\\:\\ 0\\.017951068912323526\ \(0\)\
\-\ leak\\:\\ 0\\.017862853553493246\ \(0\)\
\-\ l3\\:\\ 0\\.017862853553493246\ \(0\)\
\-\ l4\\:\\ 0\\.017610865185619985\ \(0\)\
\-\ closure\\:\\ 0\\.017610865185619985\ \(0\)\
\-\ capillary\\:\\ 0\\.017530762334662848\ \(0\)\
\-\ varying\\:\\ 0\\.017452459701031982\ \(0\)\
\-\ angioma\\:\\ 0\\.017452459701031982\ \(0\)\
\-\ cutaneous\\:\\ 0\\.01730094363155554\ \(0\)\
\-\ proven\\:\\ 0\\.016948692353258084\ \(0\)\
\-\ presumed\\:\\ 0\\.016882322335938595\ \(0\)\
\-\ l5\\:\\ 0\\.01669047642240888\ \(0\)\
\-\ s2\\:\\ 0\\.01639248975537696\ \(0\)\
\-\ elements\\:\\ 0\\.0163358328882279\ \(0\)\
\-\ due\\:\\ 0\\.015890433121622576\ \(0\)\
\-\ inferiorly\\:\\ 0\\.0156264288629971\ \(0\)\
\-\ subcutaneous\\:\\ 0\\.015491535092332672\ \(0\)\
\-\ meningitis\\:\\ 0\\.015447706582901103\ \(0\)\
\-\ t2\\-weighted\\:\\ 0\\.015076244091408916\ \(0\)\
\-\ extend\\:\\ 0\\.014923062476701192\ \(0\)\
\-\ help\\:\\ 0\\.014848925199881385\ \(0\)\
\-\ baby\\:\\ 0\\.014500202347766463\ \(0\)\
\-\ birth\\:\\ 0\\.014306579173011025\ \(0\)\
\-\ 70\\:\\ 0\\.014306579173011025\ \(0\)\
\-\ become\\:\\ 0\\.014183227510812711\ \(0\)\
\-\ into\\:\\ 0\\.01416952172794221\ \(0\)\
\-\ noted\\:\\ 0\\.014114433369007622\ \(0\)\
\-\ associated\\:\\ 0\\.014052003915733115\ \(0\)\
\-\ lipoma\\:\\ 0\\.013920685917635754\ \(0\)\
\-\ demonstrate\\:\\ 0\\.01370349924273896\ \(0\)\
\-\ component\\:\\ 0\\.013598827659339535\ \(0\)\
\-\ must\\:\\ 0\\.013573301387241719\ \(0\)\
\-\ present\\:\\ 0\\.013449538354924606\ \(0\)\
\-\ lower\\:\\ 0\\.013392767033894514\ \(0\)\
\-\ from\\:\\ 0\\.013238003970253091\ \(0\)\
\-\ surface\\:\\ 0\\.01314318225452004\ \(0\)\
\-\ until\\:\\ 0\\.013076388121740527\ \(0\)\
\-\ difficult\\:\\ 0\\.01303255961230896\ \(0\)\
\-\ rupture\\:\\ 0\\.012641577066640219\ \(0\)\
\-\ tube\\:\\ 0\\.01254558420333628\ \(0\)\
\-\ csf\\:\\ 0\\.012433778229289242\ \(0\)\
\-\ sequences\\:\\ 0\\.012433778229289242\ \(0\)\
\-\ formation\\:\\ 0\\.012290074541017293\ \(0\)\
\-\ thin\\:\\ 0\\.012237677755774992\ \(0\)\
\-\ occurs\\:\\ 0\\.012220385806847712\ \(0\)\
\-\ tissues\\:\\ 0\\.012220385806847712\ \(0\)\
\-\ at\\:\\ 0\\.012102053862351565\ \(0\)\
\-\ results\\:\\ 0\\.012019311529423857\ \(0\)\
\-\ symptomatic\\:\\ 0\\.011829210539004223\ \(0\)\
\-\ failure\\:\\ 0\\.011663617710213821\ \(0\)\
\-\ unknown\\:\\ 0\\.011619789200782254\ \(0\)\
\-\ structures\\:\\ 0\\.01146364280430214\ \(0\)\
\-\ compression\\:\\ 0\\.01114546106724713\ \(0\)\
\-\ otherwise\\:\\ 0\\.01069447816524859\ \(0\)\
\-\ typically\\:\\ 0\\.01051019431883614\ \(0\)\
\-\ to\\:\\ 0\\.010416295327877714\ \(0\)\
\-\ boy\\:\\ 0\\.01012098181158875\ \(0\)\
\-\ extending\\:\\ 0\\.010009474037769328\ \(0\)\
\-\ cases\\:\\ 0\\.009919201616658999\ \(0\)\
\-\ by\\:\\ 0\\.009915476677664632\ \(0\)\
\-\ back\\:\\ 0\\.009822530785182847\ \(0\)\
\-\ a\\:\\ 0\\.009673165898014665\ \(0\)\
\-\ t1\\:\\ 0\\.009437266676739525\ \(0\)\
\-\ area\\:\\ 0\\.00941406356841208\ \(0\)\
\-\ any\\:\\ 0\\.009375731822551546\ \(0\)\
\-\ during\\:\\ 0\\.0091115304875394\ \(0\)\
\-\ month\\:\\ 0\\.008932454845995155\ \(0\)\
\-\ infection\\:\\ 0\\.008655110014190965\ \(0\)\
\-\ focal\\:\\ 0\\.008503462035325442\ \(0\)\
\-\ through\\:\\ 0\\.008456296231431598\ \(0\)\
\-\ 4\\:\\ 0\\.008296069356024548\ \(0\)\
\-\ if\\:\\ 0\\.00807924541386981\ \(0\)\
\-\ up\\:\\ 0\\.008006436066391022\ \(0\)\
\-\ patients\\:\\ 0\\.007705834840996606\ \(0\)\
\-\ in\\:\\ 0\\.007341415159237891\ \(0\)\
\-\ the\\:\\ 0\\.007225572371269641\ \(0\)\
\-\ \\%\\:\\ 0\\.006945369454167274\ \(0\)\
\-\ posterior\\:\\ 0\\.006862852086071249\ \(0\)\
\-\ mri\\:\\ 0\\.006840682421305296\ \(0\)\
\-\ it\\:\\ 0\\.006692851514052323\ \(0\)\
\-\ but\\:\\ 0\\.006350185717886891\ \(0\)\
\-\ that\\:\\ 0\\.005142789994978478\ \(0\)\
\-\ ct\\:\\ 0\\.004164821091958338\ \(0\)\
\-\ an\\:\\ 0\\.004117299178692438\ \(0\)\
\-\ history\\:\\ 0\\.004112245775982869\ \(0\)\
\-\ are\\:\\ 0\\.004058793980939379\ \(0\)\
\-\ is\\:\\ 0\\.003918402636827356\ \(0\)\
\-\ of\\:\\ 0\\.00365342929331671\ \(0\)\
\-\ was\\:\\ 0\\.003443475687155703\ \(0\)\
\-\ this\\:\\ 0\\.003348910150920324\ \(0\)\
\-\ old\\:\\ 0\\.003048552602307507\ \(0\)\
\-\ no\\:\\ 0\\.00299806324287039\ \(0\)\
\-\ \\,\\:\\ 0\\.0028297219392050947\ \(0\)\
\-\ for\\:\\ 0\\.002540446510950227\ \(0\)\
\-\ on\\:\\ 0\\.002522268335768042\ \(0\)\
\-\ \\(\\:\\ 0\\.0025169398126963782\ \(0\)\
\-\ and\\:\\ 0\\.002508836316825344\ \(0\)\
\-\ \\)\\:\\ 0\\.002486194049175279\ \(0\)\
\-\ \\.\\:\\ 0\\.0017316846876754281\ \(0\)\
\-\ with\\:\\ 0\\.001223040168187001\ \(0\)\
